FDAnews
www.fdanews.com/articles/175227-tribogenics-scores-investment-from-nikon-unit

Tribogenics Scores Investment from Nikon Unit

February 5, 2016

Los Angeles-based Tribogenics has won a strategic investment from Nikon Americas, a subsidiary of Nikon.

The investment is intended to help speed up the commercialization of the Watson handheld XRF analyzer products. Watson uses X-ray technology refined by scientists at Tribogenics and UCLA.

“Last year, we first commercialized our technology and deployed Watson XRF analyzers to customers in the western United States,” Tribogenics CEO Dale Fox says in a statement. “Now, together with Nikon Group, we will expand our growth to customers across the USA and eventually into the overseas market.” — Elizabeth Hollis